05 March 2017 : Laboratory Research
Evaluation of 6-chloro-N-[3,4-disubstituted-1,3-thiazol-2(3H)-ylidene]-1,3-benzothiazol-2-amine Using Drug Design Concept for Their Targeted Activity Against Colon Cancer Cell Lines HCT-116, HCT15, and HT29
DOI: 10.12659/MSM.899646
Med Sci Monit 2017; 23:1146-1155
HTML version available soon